Doxil — The First FDA-Approved Nano-Drug: From an Idea to a Product - Harnessing Biomaterials in Nanomedicine: Preparation, Toxicity, and Applications - page 396

Richardson, V.J., Ryman, B.E., Jewkes, R.F. et al. , Tissue distribution and tumor
localization of technetium-99M labeled liposomes in cancer patients.
Br. J. Cancer , 40 , 35-43 (1979).
Schroeder, A., Avnir Y., Weisman, S., Najajreh, Y., Gabizon, A., Talmon, Y.,
Kost, J., and Barenholz, Y., Controlling liposomal drug release with low
frequency ultrasound: mechanism and feasibility, Langmuir , 23 (7):
4019-4025 (2007).
Schroeder, A., Honen, R., Turjeman, K., Gabizon, A., Kost, J., and Barenholz,
Y., Ultrasound triggered release of cisplatin from liposomes in murine
tumors, J. Control. Release, 137, 63-68 (2009a).
Schroeder, A., Kost, J., and Barenholz, Y., Ultrasound, liposomes, and drug
delivery: principles for using ultrasound to control the release of drugs
from liposomes, Chem. Phys. Lipids , 162 , 1-16 (2009b).
Sculier, J.P., Coune, A., Brassine, C., et al. , Intravenous infusion of high doses of
liposomes containing NSC 251635, a water-insoluble cytostatic agent.
A pilot study with pharmacokinetic data, J. Clin. Oncol. , 4 , 789-797
(1986).
Sculier, J.P., Coune, A., Meunier, F., et al. , Pilot study of amphotericin B
entrapped in sonicated liposomes in cancer patients with fungal
infections, Eur. J. Cancer Clin. Oncol. , 24 , 527-538 (1988).
Skeel, R.T., Handbook of Cancer Chemotherapy , 5th Edition, Lippincott
Williams & Wilkins, Philadelphia, pp. 100-101 (1999).
Storm, G., Roerdink, F.H., Steerenberg, P.A., de Jong, W.H., and Crommelin,
D.J.A., Influence of lipid composition on the antitumor activity exerted
by doxorubicin-containing liposomes in a rat solid tumor model.
Cancer Res . 47 , 3366-3372 (1987).
Stein, W.D., Transport and Diffusion Across Cell Membranes , Academic Press,
Orlando, FL, Chapter 2 (1986).
Solomon, R., and Gabizon, A.A., Clinical pharmacology of liposomal
anthracyclines: focus on pegylated liposomal doxorubicin. Clin.
Lymphoma Myeloma , 8 , 21-32 (2008).
Symon, Z., Peyser, A., Tzemach, D., Lyass, O., Sucher, E., Shezen, E., and Gabizon,
A, Selective delivery of doxorubicin to patients with breast carcinoma
metastases by Stealth liposomes, Cancer , 86 , 72-78 (1999).
Szebeni, J., and Barenholz, Y., Chapter 11, Complement Activation,
Immunogenicity, and Immune Suppression as Potential Side Eff ects of
Liposomes, This topic (2011).
Szebeni, J., Alving, C.R., Rosivall, L., Bunger, R., Baranyi, L., Bedocs, P., Toth,
M., and Barenholz, Y., Animal models of complement-mediated
hypersensitivity reactions to liposomes and other lipid-based
nanoparticles, J. Liposome Res. 17 , 1-11 (2007).